Methyl 2-(4-cyanophenyl)-2-methylpropanoate, 95.0%, 250mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-methionine>98.0%(HPLC)(T)1g

2-(Trifluoromethyl)-1H-imidazole, 95.0%, 25g

4-(Dimethyltriazeno)imidazole-5-carboxamide, 97.0%, 5g

4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one, 95+%, 10g

1-(4-Chlorophenethyl)-5-oxopyrrolidine-3-carboxylic acid, 95%, 250mg

(R)-2-((tert-Butoxycarbonyl)amino)-4-(3-chlorophenyl)butanoic acid, 95%, 250mg

Nile Red, 98+%, 10g

2-(3-Chloropropoxy)-1-methoxy-4-nitrobenzene, 95.0%, 5g

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 5 ml, 1000000 dalton(s), 12 pièce(s)

2,5-Dihydroxybenzaldehyde>98.0%(GC)1g

4-(Trifluoromethyl)benzylamine, 98.0%, 1g

Methyl 4-(diethylcarbamoyl)benzoate, 95.0%, 5g